TEM
Tempus is a healthcare company that builds a vast library of clinical and molecular data and an operating system to make that data accessible and useful, starting with cancer. It focuses on precision medicine by enabling clinicians and researchers to analyze integrated datasets to inform diagnosis, treatment decisions, and clinical trial selection. Headquartered in the United States with global reach, Tempus collaborates across oncology, neurology, cardiology, radiology, and life sciences to accelerate patient care and drug development.
No recent news for this company.
No recent deals for this company.